Testimony
Featured Topics
Lead story
Other featured articles
-
Scrutinizing the Role of Pharmacy Benefit Managers
Policymakers should consider increasing transparency, explore alternatives to the rebate system, scrutinize vertical integration, and seek better alignment of PBM incentives with patient and payer interests.
Posted in -
Pharmaceutical Pricing That Balances Innovation and Affordability for Patients with Rare Diseases
Alternative financing mechanisms for drugs that deliver significant long-term value for patients could strike a balance between encouraging innovation and accessibility.
Posted in -
Ensuring Affordable and Valuable Pharmaceutical Innovation for Americans
Aligning drug prices with the actual value provided to patients stimulates innovation that benefits patients and discourages innovation that does not.
Posted in -
Examining Policies that Inhibit Innovation and Patient Access
Americans have benefited substantially from new medical treatments, and the United States serves as the engine of medical innovation for the world.
Posted in
ADDITIONAL TESTIMONY
-
Testimony on Pharmacy Benefit Managers and the Prescription Drug Supply Chain
Karen Van Nuys spoke to the Senate Finance Committee on March 30, 2023 about the role PBMs play in the pharmaceutical distribution system.
-
Testimony on Bringing Transparency and Accountability to Pharmacy Benefit Managers Â
Erin Trish spoke at the Senate Committee on Commerce, Science, & Transportation on February 16, 2023 about the complex and influential role that PBMs play in the pharmaceutical distribution system.
-
Potential Impacts of Recreational Marijuana Policies and Regulatory Structures that Could Reduce its Negative Impacts
Rosalie Liccardo Pacula presented before the Florida House of Representatives Health & Human Services Committee, Subcommittee on Health Quality on Dec. 11, 2019 about regulations to govern the use of recreational marijuana.
-
Medicare Physician Payment Reform After Two Years: Examining MACRA Implementation and the Road Ahead
Matthew Fiedler spoke at the Senate Finance Committee on May 8 about the implementation of the Medicare physician payment provisions of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Categorized in -
Examining Surprise Billing: Protecting Patients from Financial Pain
Christen Linke Young delivered testimony to the House Education and Labor Subcommittee on Health, Employment, Labor, and Pensions on April 2, 2019.
Categorized in -
Testimony on Texas v. U.S.: The Republican Lawsuit and its Impacts on Americans with Pre- Existing Conditions
Christen Linke Young delivered testimony to the House Energy & Commerce Subcommittee on Health on February 6, 2019.
Categorized in